SFA Disease

Advertisement

cGxPJobs Banner

Endologix Reports 3-Year DETOUR2 Trial Success in PAD

SANTA ROSA, Calif., July 2, 2026 Endologix LLC announced the publication of 36-month results from its DETOUR2 clinical trial...

By cGxPwire Editor
July 3, 2026

Read More

Advertisement

cGxPJobs

Directory